BIOMARIN PHARMACEUTICAL INC
Reported by NEW YORK STATE COMMON RETIREMENT FUND
Reported 0 shares, down 2,261,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
55 managers reported BIOMARIN PHARMACEUTICAL INC for Q1 2020.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Invesco Ltd | Unchanged | 42,266,000 | 0 | 0.02% | $44,804,000 | 26 qtrs |
| Allianz Asset Management GmbH | Reduced | 34,985,000 | -17,970,000 | 0.05% | $37,086,000 | 20 qtrs |
| Calamos Advisors LLC | Reduced | 32,553 | -16,469 | 0.27% | $34,509,000 | 26 qtrs |
| FRANKLIN RESOURCES INC | Unchanged | 29,700,000 | 0 | 0.02% | $31,558,000 | 26 qtrs |
| Bank of America Corporation | Added | 26,816,000 | +14,700,000 | < 0.01% | $28,427,000 | 26 qtrs |
| ROYAL BANK OF CANADA | Reduced | 20,680,000 | -18,195,000 | 0.01% | $21,883,000 | 26 qtrs |
| Polar Capital LLP | Reduced | 19,050,000 | -18,173,000 | 0.22% | $20,242,000 | 2 qtrs |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | Unchanged | 0 | 0 | 1.94% | $18,095,000 | 1 qtr |
| ADVENT CAPITAL MANAGEMENT DE | Reduced | 15,004,000 | -22,777,000 | 0.35% | $15,899,000 | 26 qtrs |
| STATE STREET CORPORATION | Reduced | 10,600,000 | -1,700,000 | < 0.01% | $11,304,000 | 11 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2020
- Filed
- May 06, 2020
- Filing type
- 13F-HR
- Position type
- Convertible Debt
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.